Importantly, consistent with the pro-invasive/EMT effects of the USP19-CY variant, we revealed that USP19-CY is more highly expressed in breast cancer tissues than in phenotypically normal adjacent tissues, and the higher expression level is related to more advanced cancer stages. The gene discussed is USP19; the disease is breast cancer.